Evidence map›Paper›PMID 41606782›Full record

ArticleBMC medical informatics and decision making2026

Automated abstraction of clinical parameters of multiple myeloma from real-world clinical notes using large language models.

Alana O'Brien Del Campo, Dmytro Lituiev, Gowtham Varma, Mithun Manoharan, Sunil Kumar Ravi, Avinash Aman, Ankit Kansagra, Joel Greshock, A J Venkatakrishnan, Ashita S Batavia

Abstract read
In one paragraph

Article in BMC medical informatics and decision making, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Alana O'Brien Del Campo *Johnson & Johnson Innovative Medicine, 301 Binney Street, Cambridge, MA, 02142, USA.
Dmytro Lituiev *Johnson & Johnson Innovative Medicine, 1 Johnson & Johnson Plaza, New Brunswick, NJ, 08933, USA.
Gowtham Varma *nference, 3rd, 4th & 5th Floor, Indiqube Golf View Homes, 3rd Cross, Rustam Bagh Layout, NAL Wind Tunnel Main Road, Murugeshpalya, Bengaluru, 560017, India.
Mithun Manoharannference, 3rd, 4th & 5th Floor, Indiqube Golf View Homes, 3rd Cross, Rustam Bagh Layout, NAL Wind Tunnel Main Road, Murugeshpalya, Bengaluru, 560017, India.
Sunil Kumar Ravinference, 3rd, 4th & 5th Floor, Indiqube Golf View Homes, 3rd Cross, Rustam Bagh Layout, NAL Wind Tunnel Main Road, Murugeshpalya, Bengaluru, 560017, India.
Avinash Amannference, 3rd, 4th & 5th Floor, Indiqube Golf View Homes, 3rd Cross, Rustam Bagh Layout, NAL Wind Tunnel Main Road, Murugeshpalya, Bengaluru, 560017, India.
Ankit KansagraJohnson & Johnson Innovative Medicine, 920 US Route 202 South, Raritan, NJ, 08869, USA.
Joel GreshockJohnson & Johnson Innovative Medicine, 965 Chesterbrook Boulevard, Wayne, PA, 19087, USA.
A J Venkatakrishnannference, One Main Street, Suite 400 East Arcade, 4th Floor, Cambridge, MA, 02142, USA. aj@nference.net.
Ashita S BataviaJohnson & Johnson Innovative Medicine, 1 Johnson & Johnson Plaza, New Brunswick, NJ, 08933, USA. abatavia@its.jnj.com.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundReal-world evidence (RWE) is increasingly recognized as a valuable type of oncology research but extracting fit-for-purpose real-world data (RWD) from electronic health records (EHRs) remains challenging. Manual abstraction from free-text clinical documents, although the gold standard for information extraction, is resource-intensive. RWD generation using natural language processing (NLP) has been limited by performance ceilings and annotation requirements, which recent LLMs improve on. Multiple myeloma (MM) is the second most common hematological malignancy, with many opportunities for RWE to expand knowledge of disease and treatment. We evaluate new NLP workflows in abstracting MM-related clinical data fields from de-identified EHRs.

methodsNLP workflows (BERT and Llama-based, using various prompt types) were developed for 12 MM-specific data fields and evaluated with manually curated data from 125 clinical notes. Statistical analysis was conducted to evaluate characteristics of models and data associated with F1 scores. For 200 randomly selected patients, three illustrative data fields (MM status, transplant status, and extramedullary disease) were extracted with a corresponding timestamp from all patient notes within a 120-day window of the index MM diagnosis date using the best-performing Llama workflow. Abstracted data field labels were then plotted on a timeline to display the frequency with which these data fields are documented in patient records.

resultsAverage F1 across the 12 data fields for the best Llama and BERT workflows was 0.82 and 0.65 respectively. Best workflow performance ranged across the data fields (F1 = 0.59–0.99). Statistical analysis of the results showed model size, inter-rater reliability (IRR), variable type, and prompt design significantly predicted workflow performance, in descending order of significance (p < 0.05).

conclusionPerformance improvements with larger LLMs and chain-of-thought prompting was greater in data fields with greater difficulty of abstraction. IRR can prioritize NLP resources, increasing efficiency of RWD generation without sacrificing data quality. Strategic selection of NLP tool using the proposed framework has the potential to inform planning of RWD generation, ultimately accelerating insights from RWE.

Indexed as

Data MiningElectronic Health RecordsLarge Language ModelsMultiple MyelomaNatural Language ProcessingHumansLarge language modelsMultiple myelomaNatural language processingReal world data

Identifiers

PMID41606782
PMCPMC12924526

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.